Retrospective Study
Copyright ©The Author(s) 2019.
World J Hepatol. Feb 27, 2019; 11(2): 208-216
Published online Feb 27, 2019. doi: 10.4254/wjh.v11.i2.208
Table 1 Clinical and demographic data at time of liver transplant listing and short-term clinical outcome of patients with and without central line-associated bloodstream infection
No CLABSICLABSIP value
n (%)44 (70)19 (30)
Male, n (%)11 (25)5 (26)0.91
Race, n (%)
White38 (86)15 (79)0.71
Black5 (11)3 (16)
Asian1 (2)1 (5)
Ethnicity, n (%)
Hispanic25 (57%)9 (47%)0.49
Primary language non-English, n (%)12 (27)3 (16)0.32
Insurance, n (%)0.036
Public/none25 (57)16 (84)
Private19 (43)3 (16)
Kasai portoenterostomy timing, n (%)0.99
≤ 100 d28 (64)12 (63)
> 100 d2 (5)1 (5)
Not performed14 (32)6 (32)
Age at listing, years, mean (SD)0.59 (0.27)0.61 (0.31)0.89
Any home parenteral nutrition, n (%)16 (36)9 (47)0.41
Anthropometrics
Length, cm, mean (SD)64.5 (3.8)64.3 (3.6)0.82
Weight, kg, mean (SD)6.9 (1.3)6.6 (1.1)0.38
Length z-score, mean (SD)-1.26 (1.47)-1.57 (1.24)0.43
Weight z-score, mean (SD)-0.96 (1.26)-1.44 (0.98)0.15
WFL z-score, mean (SD)-0.21 (1.13)-0.58 (0.91)0.21
Laboratory
ALT, U/L, median (25th, 75th)133 (90, 204)128 (90, 233)0.98
GGT, U/L, median (25th, 75th)257 (106, 504)364 (205, 800)0.14
Albumin, g/dL, mean (SD)3.1 (0.46)3 (0.68)0.88
Conjugated bilirubin, mg/dL, median (25th, 75th)4.2 (0.95, 8.2)3.7 (2, 5.7)0.73
Total bilirubin, mg/dL, median (25th, 75th)10.7 (3.5, 16.2)11.3 (6.2, 12.7)0.90
White blood cells, × 103/µL, median (25th, 75th)10.2 (8.3, 15.6)10.6 (7.4, 14.4)0.88
Hemoglobin, g/dL, mean (SD)9.9 (1.6)10.2 (1.3)0.56
Platelets, × 103/µL, median (25th, 75th)123 (95, 217)160 (102, 230)0.41
INR, mean (SD)1.6 (0.6)2.3 (4.1)0.28
BUN, mg/dL, mean (SD)9.5 (5)9.9 (4.6)0.73
Prealbumin, mg/dL, mean (SD)9.5 (3.6)9.5 (4.3)0.95
Clinical outcome0.29
Transplanted35 (80)18 (95)
Died on the waitlist or removed for too ill6 (14)1 (5)
Removed from waitlist for too well3 (7)0